Drugmaker Merck announces approval of new cholesterol-fighting drug

Published July 16, 2026 · Category: News

Overview

Lipfendra can be taken in conjunction with or an alternative to statins, the most prescribed medication in the US

• Sign up for the Breaking News US newsletter email

The drug giant Merck on Thursday announced it had received FDA approval for a daily pill that can be an alternative to statins for treating high LDL levels, or so-called bad cholesterol. The new pill, Lipfendra, is a version of a drug called a PCSK9 inhibitor.

Details

For decades the go-to therapy to treat high cholesterol levels has been statins, the most prescribed medication in the US. But statins come occasionally with side-effects like muscle aches and they sometimes don’t drop cholesterol levels enough to meet recommended levels.

Source

Originally published at www.theguardian.com.

Related Articles

• What next for England? How does Tuchel fix key problems for Euro 2028?
• Uncle of Ann Widdecombe suspect says he 'nearly fell to floor' over arrest
• Hamas leadership run-off expected between Meshaal and al-Hayya